Glomeria Therapeutics
Chieti
About Glomeria Therapeutics
Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis. Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.3M
- Last round: Grant (Oct 2016)
- Website: glomeria.comen
- Phone: +390871562276
Industries & Categories
Biotechnology, Emergency Medicine, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/glomeria-therapeutics-2241641 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.